Morgan Stanley Asia (Singapore) has sold 14.98 lakh shares of Granules India through the open market route. The shares were sold on an average price of Rs 85.12 valuing the transaction to Rs 12.76 crore.
Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.
